The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Neumann, J.
Right arrow Articles by Koch, N.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Neumann, J.
Right arrow Articles by Koch, N.
Right arrowPubmed/NCBI databases
*Substance via MeSH
The Journal of Immunology, 2003, 171: 3075-3083.
Copyright © 2003 by The American Association of Immunologists

Herpes Simplex Virus Type 1 Targets the MHC Class II Processing Pathway for Immune Evasion 1

Jürgen Neumann*, Anna Maria Eis-Hübinger{dagger} and Norbert Koch2,*

* Section of Immunobiology, Institute for Molecular Physiology, University of Bonn, Bonn, Germany; and {dagger} Institute for Medical Microbiology and Immunology, University of Bonn Medical Center, Bonn, Germany

HSV type 1 (HSV-1) has evolved numerous strategies for modifying immune responses that protect against infection. Important targets of HSV-1 infection are the MHC-encoded peptide receptors. Previous studies have shown that a helper T cell response and Ab production play important roles in controlling HSV-1 infection. The reduced capacity of infected B cells to stimulate CD4+ T cells is beneficial for HSV-1 to evade immune defenses. We investigated the impact of HSV-1 infection on the MHCII processing pathway, which is critical to generate CD4+ T cell help. HSV-1 infection targets the molecular coplayers of MHC class II processing, HLA-DR (DR), HLA-DM (DM), and invariant chain (Ii). HSV-1 infection strongly reduces expression of Ii, which impairs formation of SDS-resistant DR-peptide complexes. Residual activity of the MHC class II processing pathway is diminished by viral envelope glycoprotein B (gB). Binding of gB to DR competes with binding to Ii. In addition, we found gB associated with DM molecules. Both, gB-associated DR and DM heterodimers are exported from the endoplasmic reticulum, as indicated by carbohydrate maturation. Evaluation of DR, DM, and gB subcellular localization revealed abundant changes in intracellular distribution. DR-gB complexes are localized in subcellular vesicles and restrained from cell surface expression.




This article has been cited by other articles:


Home page
J. Immunol.Home page
A. G. Aleyas, J. A. George, Y. W. Han, M. M. Rahman, S. J. Kim, S. B. Han, B. S. Kim, K. Kim, and S. K. Eo
Functional Modulation of Dendritic Cells and Macrophages by Japanese Encephalitis Virus through MyD88 Adaptor Molecule-Dependent and -Independent Pathways
J. Immunol., August 15, 2009; 183(4): 2462 - 2474.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
C. D. Conrady, M. Thapa, T. Wuest, and D. J. J. Carr
Loss of Mandibular Lymph Node Integrity Is Associated with an Increase in Sensitivity to HSV-1 Infection in CD118-Deficient Mice
J. Immunol., March 15, 2009; 182(6): 3678 - 3687.
[Abstract] [Full Text] [PDF]


Home page
JEMHome page
N. Iijima, M. M. Linehan, M. Zamora, D. Butkus, R. Dunn, M. R. Kehry, T. M. Laufer, and A. Iwasaki
Dendritic cells and B cells maximize mucosal Th1 memory response to herpes simplex virus
J. Exp. Med., December 22, 2008; 205(13): 3041 - 3052.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
A. Hussain, C. Wesley, M. Khalid, A. Chaudhry, and S. Jameel
Human Immunodeficiency Virus Type 1 Vpu Protein Interacts with CD74 and Modulates Major Histocompatibility Complex Class II Presentation
J. Virol., January 15, 2008; 82(2): 893 - 902.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
A. A. Chentoufi, X. Zhang, K. Lamberth, G. Dasgupta, I. Bettahi, A. Nguyen, M. Wu, X. Zhu, A. Mohebbi, S. Buus, et al.
HLA-A*0201-Restricted CD8+ Cytotoxic T Lymphocyte Epitopes Identified from Herpes Simplex Virus Glycoprotein D
J. Immunol., January 1, 2008; 180(1): 426 - 437.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
L. Bellner, J. Karlsson, H. Fu, F. Boulay, C. Dahlgren, K. Eriksson, and A. Karlsson
A Monocyte-Specific Peptide from Herpes Simplex Virus Type 2 Glycoprotein G Activates the NADPH-Oxidase but Not Chemotaxis through a G-Protein-Coupled Receptor Distinct from the Members of the Formyl Peptide Receptor Family
J. Immunol., November 1, 2007; 179(9): 6080 - 6087.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
E. J. Wiertz, R. Devlin, H. L. Collins, and M. E. Ressing
Herpesvirus Interference with Major Histocompatibility Complex Class II-Restricted T-Cell Activation
J. Virol., May 1, 2007; 81(9): 4389 - 4396.
[Full Text] [PDF]


Home page
J. Virol.Home page
M. Mulvey, C. Arias, and I. Mohr
Maintenance of Endoplasmic Reticulum (ER) Homeostasis in Herpes Simplex Virus Type 1-Infected Cells through the Association of a Viral Glycoprotein with PERK, a Cellular ER Stress Sensor
J. Virol., April 1, 2007; 81(7): 3377 - 3390.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
L. Liang and B. Roizman
Herpes simplex virus 1 precludes replenishment of the short-lived receptor of tumor necrosis factor alpha by virion host shutoff-dependent degradation of its mRNA.
J. Virol., August 1, 2006; 80(15): 7756 - 7759.
[Abstract] [Full Text] [PDF]


Home page
J. Leukoc. Biol.Home page
A. Iannello, O. Debbeche, E. Martin, L. H. Attalah, S. Samarani, and A. Ahmad
Viral strategies for evading antiviral cellular immune responses of the host
J. Leukoc. Biol., January 1, 2006; 79(1): 16 - 35.
[Abstract] [Full Text] [PDF]


Home page
J. Gen. Virol.Home page
H. Lauterbach, C. Ried, A. L. Epstein, P. Marconi, and T. Brocker
Reduced immune responses after vaccination with a recombinant herpes simplex virus type 1 vector in the presence of antiviral immunity
J. Gen. Virol., September 1, 2005; 86(9): 2401 - 2410.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 2003 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 2003 by The American Association of Immunologists, Inc. All rights reserved.